- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-Q Quarterly report
- 3 Restated Certificate of Incorporation
- 4 Five-year Competitive Advance and Revolving Credit Facility Agreement
- 4 Third Supplement Indenture
- 4 Purchase Agreement
- 4 Exchange & Registration Rights Agreement
- 4 Form of 4.00% Senior Note Due 2008
- 4 Form of 5.25% Senior Note Due 2013
- 4 Five-year Competitive Advance and Revolving Credit Facility Agreement
- 4 Indenture, Dated 10/01/2003
- 4 Registration Rights Agreement, Dated 10/01/2003
- 4 Form of Floating Rate Convertible Senior Debenture Due 2023
- 4 Purchase Agreement Dated 09/25/2003
- 15 Independent Accountants' Awareness Letter
- 31 CEO Section 302 Certification Letter
- 31 CFO 302 Section Certification Letter
- 32 CEO 906 Section Certification Letter
- 32 CFO 906 Section Certification Letter
EXHIBIT 32(a.)
Certification by the Chief Executive Officer Pursuant to 18 U. S. C. Section 1350, as
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, I, Peter R. Dolan, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003 (the “Report”), as filed with the Securities and Exchange Commission on November 12, 2003, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.
/s/ Peter R. Dolan |
Peter R. Dolan |
Chairman of the Board and Chief Executive Officer |
November 12, 2003
E-32-1